Elemental Biologics
PrivateLast Round
Seed
Apr 1, 2026
Company Overview
Elemental Biologics is a biotechnology company developing monoclonal antibody therapies for immune-driven diseases including autoimmune, inflammatory, and fibrotic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elemental Biologics Comparables
Compare Elemental Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneWalk Therapeutics | 84% | |
| Re-Aim Therapeutics | 83% | |
| Antharis Therapeutics, Inc. | 82% |
Elemental Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2026 |
Elemental Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yazbeck & Co. | Seed |
Elemental Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elemental Biologics's valuation, stock price, and market status.
Is Elemental Biologics a public or private company?
Elemental Biologics is a private company.
What is the current stock price of Elemental Biologics?
Elemental Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Elemental Biologics worth (valuation)?
Valuation information for Elemental Biologics is not publicly available.
Can I buy Elemental Biologics stock?
Elemental Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elemental Biologics's last funding round?
Elemental Biologics's most recent funding round was Seed on April 1, 2026.
Who are the main investors in Elemental Biologics?
Key investors in Elemental Biologics include Yazbeck & Co..
Will Elemental Biologics IPO soon?
No public IPO plans have been announced for Elemental Biologics.
How can I track Elemental Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elemental Biologics's secondary market activity and sign up for updates.